青光眼和眼睛的氨酸- ангиотензин-阿尔多斯特系统:关于分子信号和治疗前景的最新消息
Francesco Buonfiglio1, Norbert Pfeiffer1, Adrian Gericke1
1Departments of Ophthalmology, University Medical Center of the Johannes Gutenberg- University, Langenbeckstr.1, 55131 Mainz, Germany.
Cellular signalling
|August 10, 2024
概括
青光眼的治疗可能会准眼睛的氨酸- ангиотензин- алдостерон系统 (RAAS). 调节RAAS和使用抗氧化剂对减缓青光眼患者的视力损失有希望.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 玻璃眼是全球不可逆转失明的主要原因,其特点是视神经受损和视力丧失.
- 升高的眼内压力 (IOP) 是主要的危险因素,但并非所有患者都具有高的眼内压力,这表明其他因素也有所贡献.
- 眼部血流和免疫因素都与此有关,需要新的治疗策略,而不仅仅是减少内血压.
研究的目的:
- 研究将眼睛的氨酸- ангиотензин- алдостерон系统 (RAAS) 连接到玻璃眼病原体的分子机制.
- 总结最近关于RAAS在氧化应激,炎症和青光眼中组织重塑中的作用的发现.
- 介绍新兴的治疗策略,涉及RAAS调节剂和抗氧化剂,用于治疗青光眼.
主要方法:
- 对研究眼睛RAAS在青光眼中的研究的文献综述.
- 分析涉及普罗林因,血管素II和青光眼中的阿尔多斯特的分子通路.
- 对RAAS调节剂和抗氧化剂作为潜在的玻璃眼治疗方法的研究进行了审查.
主要成果:
- 眼部RAAS在青光眼的发展中起着重要作用.
- RAAS激活有助于氧化应激,炎症和视神经的重塑.
- 在临床前和早期临床研究中,RAAS调节剂和抗氧化剂显示出潜力.
结论:
- 针对眼部RAAS提供了一个有前途的新途径,用于治疗青光瘤.
- 使用RAAS调节剂和抗氧化剂的联合方法可以有效地减缓青光眼的进展.
- 需要进一步的研究来将这些发现转化为预防视力障碍的临床实践.
相关概念视频
Open Angle Glaucoma: Treatment
413
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
413
Glaucoma: Overview
530
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
530
Angle Closure Glaucoma: Treatment
459
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
459
Antihypertensive Drugs: Direct Renin Inhibitors
517
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
517
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
406
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
569
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
569


